📌 Association Between Risk-Reducing Surgeries and Survival in Young BRCA Carriers with Breast Cancer: Results from an International Cohort Study presented by prof Matteo Lambertini 👏🏻
#SABCS24 #GeneralSession1 #day2 @oncoalert.bsky.social #OncoAlertAF

📌 PRO B - A Superiority Randomized Controlled Trial Evaluating the Effects of Symptom Monitoring in Metastatic Breast Cancer Patients by Maria Margarete Karsten
#SABCS24 #GeneralSession1 #day2 @oncoalert.bsky.social #OncoAlertAF

📌 HER2-Directed Antibody-Drug Conjugate SHR-A1811 in the Neoadjuvant Treatment of HER2-Positive Early Breast Cancer: A Prospective, Randomized, Open-Label, Phase 2 Trial by Junjie Li
#SABCS24 #day2 #GeneralSession1 @oncoalert.bsky.social #OncoAlertAF

📌Pyrotinib or Placebo in Combination with Trastuzumab and Docetaxel for Untreated HER2-Positive Metastatic Breast Cancer (mBC): Prespecified Final Analysis of Progression-Free Survival (PFS) of the Phase 3 PHILA Trial by Binghe Xu
#SABCS24 #GeneralSession1 #day2 @oncoalert.bsky.social #OncoAlertAF